S. Li

Targeting mGluR2/3 for treatment of neurodegenerative and neuropsychiatric diseases.

Khaled S. Abd-Elrahman, S. Li, Stephen S. G. Ferguson, 2022, Pharmacology & therapeutics.

Efficient drug delivery by novel cell-penetrating peptide derived from Midkine, with two heparin binding sites braced by a length-specific helix

Jian Zhao, Fu-Jun Wang, S. Li, 2021, Journal of drug targeting.

Evaluating CCAAT Enhancer Binding Protein Delta and the Glucocorticoid Receptor as Potential Substrates of the USP 19 Deubiquitinating Enzyme

S. Li, 2017 .

Metabotropic Glutamate Receptor 2/3 Activation Improves Motor Performance and Reduces Pathology in Heterozygous zQ175 Huntington Disease Mice

S. Ferguson, Khaled S. Abd-Elrahman, Tash-Lynn L. Colson, 2021, The Journal of Pharmacology and Experimental Therapeutics.

Metabotropic Glutamate Receptor 5 Antagonism Reduces Pathology and Differentially Improves Symptoms in Male and Female Heterozygous zQ175 Huntington’s Mice

Khaled S. Abd-Elrahman, Tash-Lynn L. Colson, S. Li, 2022, Frontiers in Molecular Neuroscience.

Comparison of Huntington’s disease phenotype progression in male and female heterozygous FDNQ175 mice

Khaled S. Abd-Elrahman, Tash-Lynn L. Colson, S. Li, 2023, Molecular Brain.